A case of serious drug-induced enteritis that developed during chemoradiotherapy with S-1 in a patient with oral cancer

TANAKA Takuya, OGI Hidenao, YOSHITAKE Yoshihiro, OHTA Kazutoshi, SHINOHARA Masanori, NAKAYAMA Hideki

doi:10.5794/jjoms.62.352

Bibliographic Information

Other Title

S-1併用化学放射線療法中の口腔癌患者に生じた重篤な薬剤性腸炎の1例
S-1 ヘイヨウカガクホウシャセンリョウホウチュウノコウコウガンカンジャニショウジタジュウトクナヤクザイセイチョウエンノ 1レイ

Search this article

Description

<p>An 84-year-old woman with left mandibular gingival carcinoma received chemoradiotherapy combining S-1 (100 mg / day for 14 days) with a total dose of 20 Gy of radiotherapy. The patient had frequent diarrhea, severe myelosuppression, and renal dysfunction after therapy.</p><p>　She was therefore treated in the intensive care unit of our hospital. Abdominal computed tomography (CT) showed edema of the entire intestine, and abdominal endoscopy showed diffuse hemorrhage, mainly in the small intestine. No mucosal duct necrosis was found on histopathological examination, which was also negative for ischemic enteritis. The patient then had bloody bowel discharge, disturbed consciousness, and respiratory depression. Disseminated intravascular coagulation (DIC) was diagnosed. We intubated the trachea and started transfusion and medical treatment for DIC. The treatment reduced the symptoms and the abdominal CT findings. Chemical enterocolitis was suspected, because the endoscopy results, stool culture, and the results of the lymphocyte stimulation test for S-1 were positive. In conclusion, when a patient has frequent diarrhea during S-1 therapy, we should treat it as an aggravation of drug-induced enteritis.</p>

Journal

Japanese Journal of Oral and Maxillofacial Surgery

Japanese Journal of Oral and Maxillofacial Surgery 62 (7), 352-357, 2016

Japanese Society of Oral and Maxillofacial Surgeons

Keywords

Details 詳細情報について

Export

Report a problem